ライフサイエンスコーパス: beta-cyclodextrin

1 ion of new crystalline phases not present in beta-cyclodextrin.

2 g a high-surface-area, mesoporous polymer of beta-cyclodextrin.

3 an be prepared from various omega-3 oils and beta-cyclodextrin.

4 mutiwalled carbon nanotubes assimilated with beta-cyclodextrin.

5 ation of aqueous mixtures of omega-3 oil and beta-cyclodextrin.

6 id rafts, similar to positive control methyl-beta-cyclodextrin.

7 rbed from the film and then solubilized with beta-cyclodextrin.

8 aromatic rings of curcumin and the cavity of beta-cyclodextrin.

9 olubility by increasing the concentration of beta-cyclodextrin.

10 uperior host-guest interaction capability of beta-cyclodextrin.

11 after disruption of lipid rafts with methyl-beta-cyclodextrin.

12 epletion fully reversed the effect of methyl beta-cyclodextrin.

13 an aryl sulfonate to promote inclusion into beta-cyclodextrin.

14 eated with 7KCh solubilized in hydroxypropyl-beta-cyclodextrin.

15 following disruption of caveolae with methyl-beta-cyclodextrin.

16 ter incubating dissociated cells with methyl-beta-cyclodextrin.

17 aft domains, similar to the action of methyl-beta-cyclodextrin.

18 the nanoencapsulation of Danube fish oils in beta-cyclodextrin.

19 cubating neonatal cardiomyocytes with methyl-beta-cyclodextrin.

20 cholesterol stores were depleted with methyl-beta-cyclodextrin.

21 e ethyl esters form inclusion complexes with beta-cyclodextrin.

22 d by using aqueous solution of hydroxypropyl-beta-cyclodextrins.

23 otenoids were complexed with 2-hydroxypropyl-beta-cyclodextrin (2-HPbetaCD) in different mass ratios

24 ted with the sterol acceptor 2-hydroxypropyl-beta-cyclodextrin (2-OHCD) confirmed the release of an a

25 e independent methods: 1) exposure to methyl-beta-cyclodextrin, 2) treatment with the HMG-CoA reducta

26 An acetylated-per-azido-beta-cyclodextrin (4) was reacted with series of alkyne

27 ermore, we demonstrated that 2-hydroxypropyl-beta-cyclodextrin, a clinical agent used to enhance the

28 , the mice were treated with 2-hydroxypropyl-beta-cyclodextrin, a drug previously reported to rescue

29 anges in hysteresis due to interactions with beta-cyclodextrin, a molecule that is known to form stab

30 gradual neurodegeneration, and we reveal how beta-cyclodextrin, a potential therapeutic drug, reverts

31 prevented by treatment with 2-hydroxypropyl-beta-cyclodextrin, a promising therapy currently under c

32 zed following treatment with 2-hydroxypropyl-beta-cyclodextrin, a therapy that reduces pathological f

33 the well-known cholesterol extracting agent, beta-cyclodextrin, acts by catalytically tipping the equ

34 an those of activated carbons and non-porous beta-cyclodextrin adsorbent materials.

35 Disrupting lipid raft by methyl-beta-cyclodextrin also blocked neurite outgrowth.

36 Pharmacological raft disruption using methyl-beta-cyclodextrin also increased CD44-ezrin coprecipitat

37 ing prompted by cholesterol efflux to methyl-beta-cyclodextrin also was prevented, indicating that PM

38 tion reactions of two structurally different beta-cyclodextrins (AmPrbetaCD and AMBnTbetaCD) in the P

39 their inhibition by cationic aminopropylthio-beta-cyclodextrin, AmPrbetaCD, was studied.

40 Insoluble polymers of beta-cyclodextrin, an inexpensive, sustainably produced

41 Methyl beta-cyclodextrin, an inhibitor of caveola formation, re

42 water (calorimetric effect of 536Jg(-1) for beta-cyclodextrin and 304-422.5Jg(-1) for complexes).

43 r reactivity was only moderately affected by beta-cyclodextrin and bovine serum albumin, taken as mod

44 inct binding epitopes are capable of binding beta-cyclodextrin and cucurbit[6/7]uril (CB) simultaneou

45 into the supramolecular interactions between beta-cyclodextrin and ferrocene-nucleobase derivatives.

46 lloprotease inhibitor batimastat, and methyl-beta-cyclodextrin and filipin, which block lipid raft fo

47 ies of ferrocene-based guests with CB[7] and beta-cyclodextrin and provide a coherent view of the rol

48 n/activation was also decreased after methyl-beta-cyclodextrin and statin treatment but increased in

49 ts showed a cross-peak between H-3 proton of beta-cyclodextrin and the aromatic rings group of curcum

50 In the presence of the beta-cyclodextrin and/or pyrene-modified beta-cyclodextr

51 pyrene-modified beta-cyclodextrin rings, the beta-cyclodextrin and/or pyrene-modified beta-cyclodextr

52 nzene units leads to the dissociation of the beta-cyclodextrin and/or pyrene-modified beta-cyclodextr

53 through cholesterol-scavenging drugs (methyl-beta-cyclodextrin) and the enzymatic breakdown of sphing

54 acid, sodium dodecyl sulfate, hydroxypropyl-beta-cyclodextrin, and NaCl served as model medium const

55 g superparamagnetic iron oxide nanoparticle, beta-cyclodextrin, and polymerized paclitaxel.

56 beta-Cyclodextrin- and 2-hydroxypropyl-beta-cyclodextrin

57 Hydroxypropyl-beta-cyclodextrin/ANE (HP-beta-CD/ANE) inclusion complex

58 Chitosan chloride and methyl-beta-cyclodextrins appear therefore suitable to formulat

59 their acute cholesterol depletion by methyl-beta-cyclodextrin as a tool to describe the physiologica

60 lizing a direct compaction grade powder with beta-cyclodextrin as encapsulating agent.

61 micellar electrokinetic chromatography using beta-cyclodextrin as the chiral selector and sodium taur

62 f curcumin through inclusion complexation by beta-cyclodextrin as well as the topology and geometry o

63 and occupancy of binding sites; (ii) methyl-beta-cyclodextrin, as a FA acceptor, to observe the diss

64 For this purpose, a chiral host, beta-Cyclodextrin based copper metal organic framework (

65 Thus, the optimization of the beta-cyclodextrin-based extraction of functional compoun

66 S faces, functionalized with a pH-responsive beta-cyclodextrin-based supramolecular nanovalve on the

67 Cyclic oligosaccharide 2-hydroxypropyl-beta-cyclodextrin (BCD) is a compound that solubilizes l

68 Here, we show that beta cyclodextrins (beta-CDs) bind LBs and protect them

69 ap, 4, that is tethered via amide bonds to a beta-cyclodextrin (beta-CD) and a dodecyl chain was achi

70 on-sensitive host-guest crosslinkers between beta-cyclodextrin (beta-CD) and ferrocene (Fc) and iron

71 f the tricyclic antidepressant doxepin using beta-cyclodextrin (beta-CD) as a buffer additive is inve

72 The beta-cyclodextrin (beta-CD) capped ZnO quantum dots (QDs

73 Here, we show that by attaching beta-cyclodextrin (beta-CD) cavities to reduced graphene

74 ructural and thermodynamic insights into the beta-cyclodextrin (beta-CD) encapsulation of key compoun

75 In this study, beta-cyclodextrin (beta-CD) enhanced ultrasound assisted

76 t decreases with increasing concentration of beta-cyclodextrin (beta-CD) in an aqueous solution, and

77 with mono-6-deoxy-6-((2-mercaptoethyl)amino)-beta-cyclodextrin (beta-CD) in order to produce a select

78 d ensemble has been developed by introducing beta-cyclodextrin (beta-CD) into polymer-grafted mesopor

79 that has been chemically functionalized with beta-cyclodextrin (beta-CD) is extremely effective in af

80 le of drug delivery based on the function of beta-cyclodextrin (beta-CD) nanovalves that are responsi

81 ized nanoparticles consist of a monolayer of beta-cyclodextrin (beta-CD) rings positioned selectively

82 In this paper, beta-cyclodextrin (beta-CD) supported on porous graphene

83 erry purees through molecular inclusion with beta-cyclodextrin (beta-CD) was assessed.

84 by direct complexation with solid amorphous beta-cyclodextrin (beta-CD) was investigated.

85 The interaction of beta-cyclodextrin (beta-CD) with mixed bilayers composed

86 between rutin and four cyclodextrins, namely beta-cyclodextrin (beta-CD), (2-hydroxypropyl)-alpha-cyc

87 ole (AN) with alpha-cyclodextrin (alpha-CD), beta-cyclodextrin (beta-CD), hydroxypropyl-beta-cyclodex

88 nclusion complexes of 2-nonanone (2-NN) with beta-cyclodextrin (beta-CD), were prepared by a co-preci

89 Here we report a beta-cyclodextrin (beta-CD)-based polymer network with h

90 l materials, i.e. brown rice flour (BRF) and beta-cyclodextrin (beta-CD).

91 hich has good affinity for a model receptor, beta-cyclodextrin (beta-CD).

92 d light-responsive host-guest complexes with beta-cyclodextrin (beta-CD).

93 crocyclic hosts, cucurbit[7]uril (CB[7]) and beta-cyclodextrin (beta-CD).

94 unds in aqueous solution was investigated at beta-cyclodextrin (beta-CD)/silver nanoparticle (AgNPs)

95 Different wall materials like beta-cyclodextrin (beta-cyd), whey protein isolate (WPI)

96 ivery of CAB formulated with 2-hydroxypropyl-beta-cyclodextrin (betaCAB) and examined the pharmacokin

97 ptide LyeTxI and association compound LyeTxI/beta-cyclodextrin (betaCD) against multispecies biofilms

98 nd KR12 cationic peptides were prepared with beta-cyclodextrin (betaCD) at 1:1 molar ratios.

99 a-hemolysin (alphaHL) to map the presence of beta-cyclodextrin (betaCD) at a substrate pore opening.

100 isperse amphiphilic oligoethyleneimine (OEI)-beta-cyclodextrin (betaCD) clusters have been prepared,

101 d yellow fluorescent proteins (Fc-YFPs) onto beta-cyclodextrin (betaCD) molecular printboards was cha

102 vailable sport beverage, with and without 2% beta-cyclodextrin (betaCD) under light and darkness cond

103 of orthogonal supramolecular interactions of beta-cyclodextrin (betaCD)-adamantyl (Ad) host-guest and

104 A series of beta-cyclodextrin (betaCD)-scaffolded glycoclusters expo

105 dition of the chiral cosolvating agent (CSA) beta-cyclodextrin (betaCD).

106 ve bile acid that exhibits strong binding to beta-cyclodextrin (betaCD).

107 This study focuses on the effect of beta-cyclodextrins (betaCyD) on PPO-catalyzed reactions.

108 Abolishing CEM formation (methyl-beta-cyclodextrin) blocked OxPAPC-mediated Rac1 activati

109 m to improve the response to 2-hydroxypropyl-beta-cyclodextrin, by restoring a functional NPC1 to the

110 alent capture of olive pheromones inside the beta-cyclodextrin cavity leads to the reduction of reson

111 characterization of the rosmarinic acid (RA)-beta-cyclodextrin (CD) complex in aqueous solution by (1

112 ed carbonization (TPC) of Cu(2+)- and Fe(3+)-beta-cyclodextrin (CD) complexes, a rapid reduction of C

113 Herein we show that by appending bulky beta-cyclodextrin (CD) groups onto sheet-forming peptoid

114 between a carbohydrate-based molecule and a beta-cyclodextrin (CD) hydrophobic cavity for asymmetric

115 the particles were loaded with cargo, bulky beta-cyclodextrin (CD) molecules were noncovalently asso

116 phosphate-buffered saline (PBS), 0.1% methyl-beta-cyclodextrin (CD), or CD plus cholesterol (0.1%, CD

117 osomes prepared from DOTAP and carboxymethyl-beta-cyclodextrin (CD).

118 Dynamin inhibitors, chlorpromazine, methyl-beta-cyclodextrin, chloroquine, and concanamycin A drama

119 but following cholesterol efflux with methyl-beta-cyclodextrin, clusters containing zona-binding mole

120 arative scale by HPLC, using a permethylated beta-cyclodextrin column.

121 h excess cholesterol by a cholesterol/methyl-beta-cyclodextrin complex, phenocopying SR-BI KO oocytes

122 The formed extract: beta-cyclodextrin complexes and a physical mixture of ex

123 ridged biguanidyl adamantine (Ad-SS-GD) with beta-cyclodextrin-conjugated low-molecular-weight polyet

124 Multivalent host-guest interactions between beta-cyclodextrin-conjugated superparamagnetic iron oxid

125 ta-cyclodextrin (RAMEB) and a low methylated-beta-cyclodextrin (CRYSMEB) were investigated in aqueous

126 A single dose of 2-hydroxypropyl-beta-cyclodextrin (CYCLO) administered at 7 days of age

127 2-hydroxypropyl-beta-cyclodextrin (CYCLO), a modifier of cholesterol eff

128 beta-Cyclodextrin- and 2-hydroxypropyl-beta-cyclodextrin/Danube common nase (Chondrostoma nasus

129 The moisture content of beta-cyclodextrin/Danube fish oils complexes (common bar

130 at disrupting lipid raft formation by methyl-beta-cyclodextrin decreased NO production and apoptosis.

131 sgk1 with the apical surface, whereas methyl-beta-cyclodextrin decreased the association of sgk1 with

132 Here we measured the rate at which methyl-beta-cyclodextrin depletes cholesterol from a supported

133 sulfobutyl ether-beta-cyclodextrin (SCD), a beta-cyclodextrin derivative carrying ionizable groups t

134 dazim using gold nanorods derivatized with a beta-cyclodextrin derivative to bind this fungicide.

135 dical bTbK in complex with captisol (CAP), a beta-cyclodextrin derivative, host-guest assembling offe

136 Cationic beta-cyclodextrin derivatives were recently introduced a

137 Using this method, we determined that methyl-beta-cyclodextrin differentially extracts cholesterol fr

138 re synthesized by varying the molar ratio of beta-cyclodextrin:diphenyl carbonate (beta-CD:DPC; 1:2,

139 m parasites with cholesterol-specific methyl-beta-cyclodextrin disrupts both membrane liquid order an

140 Polyethyleneimine (PEI), Dimethyl-beta-cyclodextrin (DM-beta-CD) and Chitosan enhanced the

141 We previously reported that methyl-beta-cyclodextrin eliminates caveolae and blocks tumor n

142 enitrothion inside the cavity of per-6-amino-beta-cyclodextrin:Eu(III) complex.

143 eported for the first time using per-6-amino-beta-cyclodextrin:Eu(III) complex.

144 The per-6-amino-beta-cyclodextrin:Eu(III):pesticide complexes and their

145 ed into these vesicles using a second methyl-beta-cyclodextrin exchange step.

146 that the primary and secondary OH groups of beta-cyclodextrin exhibit markedly different dynamics, s

147 Methyl-beta-cyclodextrin extracted OA from individual sites in

148 ar-infrared fluorophores for bioimaging, and beta-cyclodextrins for potential drug delivery.

149 cells (1 mM cholesterol@randomly methylated-beta-cyclodextrin) for transport assays.

150 ent of HSV-1-infected Vero cells with methyl beta-cyclodextrin from 2 to 9 h postentry reduced plaque

151 ic strategy for controlled synthesis of thio-beta-cyclodextrin functionalized graphene/gold nanoparti

152 Poly(beta-cyclodextrin functionalized ionic liquid) immobiliz

153 ctrochemical sensor using graphene oxide and beta-cyclodextrin functionalized multiwalled carbon nano

154 ultiwalled carbon nanotubes assimilated with beta-cyclodextrin/glassy carbon electrode exhibited cata

155 2-Hydroxypropyl-beta-cyclodextrin had no effect on transcripts of neuron

156 alpha- and beta-cyclodextrins have been used as scaffolds for the s

157 eties) via controlled esterification or with beta-cyclodextrins (host moieties) through amidation.

158 yclodextrin (HP-alpha-CD), (2-hydroxypropyl)-beta-cyclodextrin (HP-beta-CD) and (2-hydroxypropyl)-gam

159 eberry, were spray-dried using hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and inulin (IN).

160 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD) has emerged as a promisin

161 tly, the cycloheptaglucoside 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) has shown efficacy as a p

162 he compact and hard HS tissue, hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was added into sodium hya

163 CNS of the npc1(-/-) mouse, 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD), a compound known to prev

164 , beta-cyclodextrin (beta-CD), hydroxypropyl-beta-cyclodextrin (HP-beta-CD), randomly methylated-beta

165 Curcumin/Hydroxypropyl-beta-Cyclodextrin (HP-beta-CyD) and Curcumin/Hydroxyprop

166 n with maltodextrin (MD) and 2-hydroxypropyl-beta-cyclodextrin (HPBCD).

167 2-Hydroxypropyl-beta-cyclodextrin (HPbetaCD) is a Food and Drug Administ

168 lation combines this drug with hydroxypropyl-beta-cyclodextrin (HPbetaCD) to improve its solubility a

169 ies reported ototoxicity of 2-hydroxypropyl- beta-cyclodextrin (HPbetaCD), a cholesterol chelator and

170 2-Hydroxy-propyl-beta-cyclodextrin (HPbetaCD), a cholesterol scavenger, i

171 izing agents, in particular, 2-hydroxypropyl-beta-cyclodextrin (HpbetaCD).

172 Furthermore, we utilized 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD, an emerging therapeutic) ad

173 In preclinical testing, 2-hydroxypropyl-beta-cyclodextrins (HPbetaCD) significantly delayed cere

174 Weekly treatment with hydroxypropyl-beta-cyclodextrin (HPCD) beginning at 7 wk reduced hepat

175 contact time, using sequential hydroxypropyl-beta-cyclodextrin (HPCD) extractions in soils amended wi

176 We employed 2-hydroxypropyl)-beta-cyclodextrin (HPCD), which was dissolved in water t

177 e, the disruption of SM-rich rafts by methyl-beta-cyclodextrin impaired myosin activation and clot re

178 O by forming a stable inclusion complex with beta-cyclodextrin in aqueous media.

179 lowed by CE-LIF using 0.5 mM hydroxyl propyl-beta-cyclodextrin in borate buffer [80 mM, pH 9.3].

180 response to postprandial micelles or methyl-beta-cyclodextrin in cultured enterocytes, and it is req

181 clodextrin is more potent than hydroxypropyl-beta-cyclodextrin in reducing both cholesterol and bis(m

182 ials (composed of sodium dodecyl sulfate and beta-cyclodextrin) in a spatially resolved manner.

183 ed with addition of a chiral selector (i.e., beta-cyclodextrin) in the running buffer.

184 lic acid (PAA) nanofibres (NF) incorporating beta-cyclodextrin inclusion complex (beta-CD-IC) of quer

185 s of glutathione thiyl radical (GS(*)); (ii) beta-cyclodextrins increase the kinetic stability of the

186 esults of this study show that carboxymethyl-beta-cyclodextrin increased lipoplexes' encapsulation ef

187 Treatment of cells with methyl-beta-cyclodextrin increased the hydrolysis rate and tota

188 t depleting cellular cholesterol with methyl-beta-cyclodextrin increased the resilience of stromal ce

189 ntain crystalline phases not present in pure beta-cyclodextrin, indicating true complexation.

190 he cells with cholesterol-deficient media or beta-cyclodextrins induced changes in cholesterol distri

191 iously described a technique in which methyl-beta-cyclodextrin-induced lipid exchange is used to prep

192 A methyl-beta-cyclodextrin-induced lipid exchange technique was d

193 revealed that the therapeutic drug candidate beta-cyclodextrin induces the subplasmalemmal location o

194 In 3T3L-1 adipocytes, apoAI, HDL, and methyl-beta-cyclodextrin inhibited chemotactic factor expressio

195 traction of membrane cholesterol with methyl-beta-cyclodextrin inhibited infection by virions but had

196 Last, we found that 2-hydroxypropyl-beta-cyclodextrin inhibits AAA in a VSMC TFEB-dependent

197 Recent studies have shown that hydroxypropyl-beta-cyclodextrin injections in npc1(-/-) mice are parti

198 Poly(beta-cyclodextrin-ionic liquid) grafted magnetic nanopar

199 beta-cyclodextrin is known to encapsulate pollutants to

200 We demonstrate that methyl-beta-cyclodextrin is more potent than hydroxypropyl-beta

201 Acute exposure of LLC-PK1 cells to methyl beta-cyclodextrin led to parallel decreases in cellular

202 TFEB activation by 2-hydroxypropyl-beta-cyclodextrin may be a promising therapeutic strateg

203 Among cyclodextrins (CDs), methyl beta cyclodextrin (MbetaCD) is the most efficient to dep

204 with the cholesterol-extracting agent methyl-beta-cyclodextrin (MbetaCD) not only disrupted the DRM l

205 Cholesterol depletion by methyl-beta-cyclodextrin (MbetaCD) remodels the plasma membrane

206 Extraction with methyl-beta-cyclodextrin (MbetaCD) removed pUL37x1/vMIA from ly

207 Treatment of cells with methyl-beta-cyclodextrin (MbetaCD) significantly reduced the DR

208 Using methyl-beta-cyclodextrin (MbetaCD) to deplete membrane choleste

209 To test this hypothesis, we used methyl-beta-cyclodextrin (MbetaCD) to load mouse peritoneal mac

210 agasi promastigotes were treated with methyl-beta-cyclodextrin (MbetaCD), a sterol-chelating reagent,

211 cholesterol levels were reduced using methyl-beta-cyclodextrin (mbetaCD), as confirmed by Amplex Red

212 Methyl-beta-cyclodextrin (MbetaCD), which disassembles caveolae

213 pid rafts, we pretreated animals with methyl-beta-cyclodextrin (MbetaCD), which disrupts lipid rafts.

214 nts were depleted of cholesterol with methyl-beta-cyclodextrin (mbetaCD).

215 etreatment with lipid raft disruptor (Methyl-beta-cyclodextrin, MbetaCD) and oxidative stress inhibit

216 Lipid raft/caveolae disruptors (methyl-beta-cyclodextrin (MCD) and Nystatin) and Ang II stimula

217 te depletion of cholesterol with 5 mm methyl-beta-cyclodextrin (MCD) caused a substantial increase in

218 with that of a simple sterol carrier, methyl-beta-cyclodextrin (MCD), when STARD4 and MCD were overex

219 In parallel, beta-cyclodextrin mediated the NPC1-independent redistri

220 Spherical chitosan chloride and methyl-beta-cyclodextrin microparticles loaded with DFO (DCH an

221 Membrane cholesterol depletion with methyl-beta-cyclodextrin mimicked the effects of AC6 silencing

222 rrelated with the increasing availability of beta-cyclodextrin moieties over the surface of the devic

223 QD functionalization with beta-cyclodextrin molecular baskets enables loading and

224 esterol depletion of macrophages with methyl-beta-cyclodextrin normalized FC content between the two

225 The aim of this work was to synthesize beta-cyclodextrin NS, by microwave-assisted fusion, for

226 The use of dynasore, PitStop2, methyl-beta-cyclodextrin, nystatin, and filipin (specific inhib

227 feasibility of synthesizing NS derived from beta-cyclodextrin of high crystallinity for the encapsul

228 ever, this trafficking was blocked by methyl-beta-cyclodextrin or by caveolin knockdown.

229 hort-term cholesterol chelation using methyl-beta-cyclodextrin or by stable knockdown of caveolin-1 a

230 Methyl-beta-cyclodextrin or caveolin knockdown significantly in

231 Depletion of cholesterol through methyl-beta-cyclodextrin or cholesterol oxidase abolished the p

232 pted by lipid raft perturbation using methyl-beta-cyclodextrin or cholesterol oxidase.

233 domains by acute exposure of cells to methyl-beta-cyclodextrin or chronic exposure to different stati

234 ted by pretreatment of the cells with methyl-beta-cyclodextrin or Filipin III, hence implicating memb

235 s rescued by cholesterol depletion by methyl-beta-cyclodextrin or mevastatin.

236 Correspondingly, pharmacological (methyl-beta-cyclodextrin) or genetic disruption of caveolae (Ca

237 toxoids or pretreatment of cells with methyl-beta-cyclodextrin) or osmotic protection of target cells

238 ore, cholesterol lowering by statins, methyl-beta-cyclodextrin, or filipin also activates PKA and, co

239 her in vitro, by treatment with 25 mM methyl-beta-cyclodextrin, or in vivo, by subjecting animals to

240 and that it does not bind to starch mimics, beta-cyclodextrin, or maltohexaose.

241 using Cab-O-sil, medium treated with methyl-beta-cyclodextrin, or serum-free medium.

242 Pretreatment of IECs with methyl-beta-cyclodextrin partially blocks OMV-induced host immu

243 linkers that attached the drug payloads to a beta-cyclodextrin-PEG copolymer to form self-assembled n

244 ic blockers, namely per-6-S-(3-amino) propyl-beta-cyclodextrin, per-6-S-(3-aminomethyl) benzyl-alpha-

245 cyclodextrin, per-6-S-(3-aminomethyl) benzyl-beta-cyclodextrin, per-6-S-(3-aminomethyl) benzyl-gamma-

246 io from intact cells does not reflect methyl-beta-cyclodextrin plasma membrane extraction properties.

247 ences and then reacted with per-O-methylated beta-cyclodextrin (PMbetaCD) caps, to form supramolecula

248 omimetic material, namely, poly(p-phenylene) beta-cyclodextrin poly(ethylene glycol) (PPP-CD-g-PEG) c

249 In the current study, beta-cyclodextrin polyester (CDPE) hydrogels serve as sa

250 A beta-cyclodextrin polymer linked with tetrafluoroterepht

251 study, we evaluated the performance of three beta-cyclodextrin polymers (CDPs), an anion-exchange (AE

252 ch was to evaluate the performance of porous beta-cyclodextrin polymers (P-CDP) as adsorbents of MPs

253 -guest complexes, but until now cross-linked beta-cyclodextrin polymers have had low surface areas an

254 er m1 or m3 muscarinic receptors with methyl-beta-cyclodextrin produced a loss of localization of pro

255 tudy we demonstrate that quaternary ammonium beta-cyclodextrin (QABCD) fulfils both of these requirem

256 ntimicrobial activity of randomly methylated beta cyclodextrin (RAMEB) encapsulated thyme oil, lemon

257 clodextrin (HP-beta-CD), randomly methylated-beta-cyclodextrin (RAMEB) and a low methylated-beta-cycl

258 ntrasts with the inhibitory effect of methyl-beta-cyclodextrin reported for other P2X subtypes.

259 ected Ae. aegypti cells with 2-hydroxypropyl-beta-cyclodextrin restores dengue replication in Wolbach

260 lesterol depletion and repletion with methyl-beta-cyclodextrin reversibly altered PI4KIIalpha associa

261 the beta-cyclodextrin and/or pyrene-modified beta-cyclodextrin rings from the stalks, thus opening th

262 the beta-cyclodextrin and/or pyrene-modified beta-cyclodextrin rings will thread onto the azobenzene-

263 the beta-cyclodextrin and/or pyrene-modified beta-cyclodextrin rings, the beta-cyclodextrin and/or py

264 e unit of the conjugates interacted with the beta-cyclodextrin's inner cavity.

265 Propofol was complexed with sulfobutyl ether-beta-cyclodextrin (SCD), a beta-cyclodextrin derivative

266 on that is palmitoylated and mediates methyl-beta-cyclodextrin-sensitive self-association of purified

267 Inclusion of CHAs with beta-cyclodextrin strongly limited these interactions to

268 mbrane cholesterol is extracted using methyl beta-cyclodextrin, suggesting that lipid raft microdomai

269 ed by the cholesterol-depleting drug, methyl beta-cyclodextrin, suggesting that the physiological fun

270 negatively charged chiral selector, sulfated beta-cyclodextrin (sulfated beta-CD), that migrated away

271 with the cholesterol chelating agent, methyl-beta-cyclodextrin, that is thought to disrupt lipid raft

272 terol-sequestering drugs nystatin and methyl-beta-cyclodextrin, the dynamin-specific inhibitor dynaso

273 The addition of carboxymethyl-beta-cyclodextrin to cationic liposomes resulted in an i

274 cells co-expressing CPM and B1R with methyl-beta-cyclodextrin to disrupt lipid rafts reduced the B1R

275 have overcome these limitations using methyl-beta-cyclodextrin to solubilize VLCFA for rapid delivery

276 turing strategy in which applying methylated beta-cyclodextrin to the culture medium allows the seque

277 y interaction, exemplified by the binding of beta-cyclodextrin to the primary and secondary binding s

278 t has been synthesized by covalently linking beta-cyclodextrin to the surface of N, S codoped carbon

279 Phe residue, (ii) site-specifically adhering beta-cyclodextrin to the surface of ubiquitin, and (iii)

280 Some cells were incubated with methyl-beta-cyclodextrin (to deplete cholesterol from membranes

281 entration of a cyclodextrin (sulfobutylether-beta-cyclodextrin) to inhibit crystallization over a 48

282 that depleting endogenous 7-DHC with methyl-beta-cyclodextrin treatment enhances Hedgehog activation

283 rose gradient ultracentrifugation and methyl-beta-cyclodextrin treatment that CLEC-2 translocates to

284 creased to approximately 79 pN/mum by methyl-beta-cyclodextrin treatment to sequester membrane choles

285 mplexes between red bell pepper pigments and beta-cyclodextrin using two different procedures (i.e.,

286 th either 3mg/kg allopregnanolone or 20% w/v beta-cyclodextrin vehicle.

287 The mass ratio of extract to beta-cyclodextrin was 1:4.

288 ion of the title compound in the presence of beta-cyclodextrin was examined in different conditions.

289 e cholesterol (cholesterol mixed with methyl-beta-cyclodextrin), we observed an increase in DAT bindi

290 plexes and a physical mixture of extract and beta-cyclodextrin were evaluated by differential scannin

291 Incubation with methyl-beta-cyclodextrin, which disrupts caveolae, or with wort

292 between bound water and the secondary OH of beta-cyclodextrin, which exhibited spatial uniformity wi

293 to the ER can be overcome by 2-hydroxypropyl-beta-cyclodextrin, which leads to a marked increase in A

294 uires coadministration with sulphobutylether-beta-cyclodextrin, which may accumulate in patients with

295 e greatest when the gradient is formed using beta-cyclodextrin while directed concentration of cyanom

296 Here we crosslink beta-cyclodextrin with rigid aromatic groups, providing

297 ntagonist or disrupting caveolae with methyl-beta-cyclodextrin, with an associated approximately 30%

298 lusion complexes of Vitamin A Palmitate with beta-cyclodextrins, without the use of organic solvents,

299 n was achieved with the expectation that the beta-cyclodextrin would lead to increased reactivity to

300 Formulation of 4c with hydroxypropyl-beta-cyclodextrin yielded good oral bioavailability, enc